Cargando…
The Clinical Significance of CD73 in Cancer
The search for new and effective treatment targets for cancer immunotherapy is an ongoing challenge. Alongside the more established inhibitory immune checkpoints, a novel potential target is CD73. As one of the key enzymes in the purinergic signalling pathway CD73 is responsible for the generation o...
Autores principales: | Bach, Niklas, Winzer, Riekje, Tolosa, Eva, Fiedler, Walter, Brauneck, Franziska |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380759/ https://www.ncbi.nlm.nih.gov/pubmed/37511518 http://dx.doi.org/10.3390/ijms241411759 |
Ejemplares similares
-
Generation and Function of Non-cell-bound CD73 in Inflammation
por: Schneider, Enja, et al.
Publicado: (2019) -
Identification of the Mouse T Cell ADP-Ribosylome Uncovers ARTC2.2 Mediated Regulation of CD73 by ADP-Ribosylation
por: Leutert, Mario, et al.
Publicado: (2021) -
The role of the ATP-adenosine axis in ischemic stroke
por: Schädlich, Ines Sophie, et al.
Publicado: (2023) -
CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression
por: Schneider, Enja, et al.
Publicado: (2021) -
Increased frequency of TIGIT(+)CD73-CD8(+) T cells with a TOX(+) TCF-1low profile in patients with newly diagnosed and relapsed AML
por: Brauneck, F., et al.
Publicado: (2021)